Cancer immunotherapy represents a transformative approach in oncology, especially for treating cancers thought to be incurable. However, a significant ...

With a market cap of $9.3 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of messenger RNA (mRNA) therapeutics and vaccines. Known for its COVID-19 vaccine ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

When director Cristina Costantini set out to make a documentary about Karol G’s record-breaking stadium tour, she knew she didn’t want to create a flashy publicity piece ...

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some ...

The U.S. stock rebound has gathered steam as the new month gets underway, confounding the old ’sell in May’ adage, largely ...

Meta Platforms (NASDAQ: META) stock climbed 6.2% after the Facebook and Instagram parent reported better-than-expected ...

Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter ... If you are looking for an AI ...

FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation ...

Moderna is currently in the very early stages of testing a bird flu vaccine using the same mRNA technology that allowed for rapid development and rollout of COVID-19 vaccines. The funds from the U ...